New leukemia drug suppresses cancer-driving protein more strongly than existing treatments within one week
A more effective and better-tolerated treatment for chronic myeloid leukemia (CML) could improve quality of life for people living with the disease. A new study led by Adelaide University and the South Australian Health and Medical Research Institute (SAHMRI) has provided the first direct evidence that a targeted therapy can rapidly and consistently suppress the molecular signals that drive CML.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Nurse-led program shown to improve midlife dementia risk profiles in new study
United Kingdom
-
Plastic tea bags are releasing BPA, plasticizers and up to 2,500 microplastic particles into your cup of tea
United Kingdom
-
Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer
United Kingdom
-
Many nondrug and nonsurgical therapies for low back pain are more cost-effective than usual care
United Kingdom
-
Highest endometrial cancer rates found in San Antonio region
United Kingdom
-
Making virtual brain models more biologically realistic by capturing ion exchange
United Kingdom
-
Planned power shutoffs aimed at preventing wildfires may increase risk of acute respiratory illness
United Kingdom
-
Baylor researchers discover how glioblastoma hijacks nearby brain cells
United Kingdom